AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)

$7.86 -0.14 (-1.75%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) News Sources

European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading

08-07-2026

yahoo.com

external link

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

20-07-2026

yahoo.com

external link

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

21-07-2026

yahoo.com

external link

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

21-07-2026

yahoo.com

external link

Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity

22-07-2026

yahoo.com

external link

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

22-07-2026

yahoo.com

external link

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

24-07-2026

yahoo.com

external link

European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading

27-07-2026

yahoo.com

external link

European Equities Traded in US as ADRs Ease in Wednesday Trading

29-07-2026

yahoo.com

external link

European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading

30-07-2026

yahoo.com

external link

AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) Sentiment Trend

0 25 50 75 100 61 64 84 62 89 66 68 61 71 61 08-07-2026 20-07-2026 21-07-2026 22-07-2026 24-07-2026 27-07-2026 29-07-2026 30-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) FAQs

toggle

What is the current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?

The current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is $7.86.


toggle

AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is $-0.14.


toggle

AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is -1.75%.


toggle

What is the most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?

The most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?

The most recent sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is .


SEC-8K** Filing Available For AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

ADXN (Addex Therapeutics Ltd ADR)
AUTL (Autolus Therapeutics Plc ADR)
AHG (Akso Health Group ADR)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.